Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews

被引:539
|
作者
Turner, Rebecca M. [1 ]
Davey, Jonathan [1 ]
Clarke, Mike J. [2 ]
Thompson, Simon G. [3 ]
Higgins, Julian P. T. [1 ]
机构
[1] MRC, Biostat Unit, Inst Publ Hlth, Cambridge CB2 0SR, England
[2] Queens Univ Belfast, Ctr Publ Hlth, All Ireland Hub Trials Methodol Res, Belfast BT7 1NN, Antrim, North Ireland
[3] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England
基金
英国医学研究理事会;
关键词
Meta-analysis; heterogeneity; intervention studies; Bayesian analysis; TRIALS;
D O I
10.1093/ije/dys041
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Many meta-analyses contain only a small number of studies, which makes it difficult to estimate the extent of between-study heterogeneity. Bayesian meta-analysis allows incorporation of external evidence on heterogeneity, and offers advantages over conventional random-effects meta-analysis. To assist in this, we provide empirical evidence on the likely extent of heterogeneity in particular areas of health care. Methods Our analyses included 14 886 meta-analyses from the Cochrane Database of Systematic Reviews. We classified each meta-analysis according to the type of outcome, type of intervention comparison and medical specialty. By modelling the study data from all meta-analyses simultaneously, using the log odds ratio scale, we investigated the impact of meta-analysis characteristics on the underlying between-study heterogeneity variance. Predictive distributions were obtained for the heterogeneity expected in future meta-analyses. Results Between-study heterogeneity variances for meta-analyses in which the outcome was all-cause mortality were found to be on average 17% (95% CI 10-26) of variances for other outcomes. In meta-analyses comparing two active pharmacological interventions, heterogeneity was on average 75% (95% CI 58-95) of variances for non-pharmacological interventions. Meta-analysis size was found to have only a small effect on heterogeneity. Predictive distributions are presented for nine different settings, defined by type of outcome and type of intervention comparison. For example, for a planned meta-analysis comparing a pharmacological intervention against placebo or control with a subjectively measured outcome, the predictive distribution for heterogeneity is a log-normal (-2.13, 1.58(2)) distribution, which has a median value of 0.12. In an example of meta-analysis of six studies, incorporating external evidence led to a smaller heterogeneity estimate and a narrower confidence interval for the combined intervention effect. Conclusions Meta-analysis characteristics were strongly associated with the degree of between-study heterogeneity, and predictive distributions for heterogeneity differed substantially across settings. The informative priors provided will be very beneficial in future meta-analyses including few studies.
引用
收藏
页码:818 / 827
页数:10
相关论文
共 50 条
  • [1] Implications of analysing time-to-event outcomes as binary in meta-analysis: empirical evidence from the Cochrane Database of Systematic Reviews
    Salika, Theodosia
    Turner, Rebecca M.
    Fisher, David
    Tierney, Jayne F.
    White, Ian R.
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2022, 22 (01)
  • [2] Implications of analysing time-to-event outcomes as binary in meta-analysis: empirical evidence from the Cochrane Database of Systematic Reviews
    Theodosia Salika
    Rebecca M. Turner
    David Fisher
    Jayne F. Tierney
    Ian R. White
    [J]. BMC Medical Research Methodology, 22
  • [3] From meta-analysis to Cochrane reviews
    Ebner, Nicole
    Banach, Maciej
    Anker, Stefan D.
    von Haehling, Stephan
    [J]. JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2018, 9 (03) : 441 - 443
  • [4] Publication bias in meta-analyses from the Cochrane Database of Systematic Reviews
    Kicinski, Michal
    Springate, David A.
    Kontopantelis, Evangelos
    [J]. STATISTICS IN MEDICINE, 2015, 34 (20) : 2781 - 2793
  • [5] Missing Data in Systematic Reviews and Meta-Analysis
    Chandelia, Sudha
    [J]. PEDIATRIC CRITICAL CARE MEDICINE, 2022, 23 (08) : E400 - E400
  • [6] Alignment of systematic reviews published in the Cochrane Database of Systematic Reviews and the Database of Abstracts and Reviews of Effectiveness with global burden-of-disease data: a bibliographic analysis
    Yoong, Sze Lin
    Hall, Alix
    Williams, Christopher M.
    Skelton, Eliza
    Oldmeadow, Christopher
    Wiggers, John
    Karimkhani, Chante
    Boyers, Lindsay N.
    Dellavalle, Robert P.
    Hilton, John
    Wolfenden, Luke
    [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2015, 69 (07): : 708 - 714
  • [7] A descriptive analysis of child-relevant systematic reviews in the Cochrane Database of Systematic Reviews
    Bow S.
    Klassen J.
    Chisholm A.
    Tjosvold L.
    Thomson D.
    Klassen T.P.
    Moher D.
    Hartling L.
    [J]. BMC Pediatrics, 10 (1)
  • [8] Robustness of meta-analysis results in Cochrane systematic reviews: A case for acupuncture trials
    Won, Jiyoon
    [J]. INTEGRATIVE MEDICINE RESEARCH, 2022, 11 (04)
  • [9] Missing Data in Systematic Reviews and Meta-Analysis Reply
    Lehr, Anab Rebecca
    d'Astous, Soha Rached
    Tsampalieros, Anne
    Barrowman, Nick
    Menon, Kusum
    [J]. PEDIATRIC CRITICAL CARE MEDICINE, 2022, 23 (08) : E401 - E401
  • [10] Systematic reviews and meta-analysis
    Lewis, G
    Churchill, R
    Hotopf, M
    [J]. PSYCHOLOGICAL MEDICINE, 1997, 27 (01) : 3 - 7